Modelling antibody dynamics in humans after different Ad26.COV2.S vaccination schemes
The model appears suitable to quantitatively describe the inter- and intraindividual kinetics of the immune response and the impact of covariates after multiple administrations of a vaccine.
Authors
- Philippe Jacqmin
- Juan José Pérez Ruixo (ORCID: https://orcid.org/0000-0001-9890-745X)
- Frank Struyf (ORCID: https://orcid.org/0000-0001-9988-0260)
- Anna Dari (ORCID: https://orcid.org/0000-0001-6972-4902)
- Mathieu Le Gars
Institutions
- Janssen (Belgium) (BE)
- Janssen (Netherlands) (NL)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1111/bcp.16251
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Janssen Research and Development